School of Medicine
Showing 9,101-9,150 of 13,025 Results
-
Stanley Qi
Associate Professor of Bioengineering and, by courtesy, of Biomedical Data Science
BioStanley Qi (publishing as Lei S. Qi) is a pioneer in the field of genome engineering and the architect of the foundational technologies that transitioned CRISPR from a "cutting" tool into a universal platform for Programmable Biology. As the inventor of CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa), Qi established the first methods for the precise, reversible, and targeted regulation of the human genome without altering the DNA sequence.
The Qi Lab integrates scalable genomic perturbation with live-cell and super-resolution imaging and computation-guided design to redefine the boundaries of cellular control. Under Dr. Qi’s leadership, the group has fundamentally expanded the genome engineering toolbox, evolving CRISPR from a single editing tool into a multidimensional platform for the precise control of dynamic and spatial cell states. This work includes establishing foundational technologies and architectures for precise epigenetic editing, multiplexed regulation of the transcriptome, programmable 3D genome organization, and spatial control of RNA logistics. By pioneering real-time visualization of chromatin dynamics and RNA in living cells, the lab provides an unprecedented window into the fundamental "control principles of life."
This principle-driven technology lineage has moved into the clinic, with the lab's compact epigenetic editor currently in first-in-human clinical testing for FSHD muscular dystrophy (NCT06907875). This milestone represents a core mission of the lab: translating foundational engineering into next-generation therapeutics that act predictably as dynamic, complex systems.
Beyond single-cell control, the Qi Lab is building a framework for synthetic cell–cell communication, with a particular emphasis on the bidirectional interplay between immune cells and neurons. The lab’s goal is to move beyond describing molecular parts to discovering fundamental control principles in living systems: how regulatory landscapes create stable states and memory, how spatial genome–RNA organization shapes dynamic responses, and how engineered cell–cell interactions can generate emergent multicellular behaviors.
By integrating computational design with experimental biology, Dr. Qi aims to identify the generalizable rules linking molecular programs to systems-level physiology. He is a Chan Zuckerberg Biohub Investigator and an Institute Scholar at the Sarafan ChEM-H, and is dedicated to shaping the technical and ethical frameworks that will define the future of human genome engineering. -
Xiang Qian
Stanford Medicine Endowed Director
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsClinical Interests
-Pain Medicine:
Facial pain
Migraine and headache
Trigeminal Neuralgia and Glossopharyngeal neuralgia
Cancer Pain
Spine Disease
Neuropathic pain
Interventional Surgery
CT guided Procedure
Opioid Management
-Facial Nerve neuralgia and neuropathy
Hemifacial Spasm
CT guided awake RFA of facial nerve
Research Interests:
-Medical device development
-AI based headache diagnosis and management
-CT guided intervention
-Intra-nasal endoscopy guided procedure
-Optogenetics
-Mechanisms of neuropathic pain
-Ion channel and diseases
-Neurotoxicity of anesthetics -
Yushen Qian, MD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Qian is a board-certified radiation oncologist and a Clinical Associate Professor in the Stanford University School of Medicine, Department of Radiation Oncology.
In his clinical practice, he sub-specializes in genitourinary (including prostate and bladder cancer) and Head and Neck malignancies, but also treats a broad spectrum of other disease subsites including lung/thoracic, gastrointestinal, brain, lymphoma, and breast tumors. For each patient, he develops a comprehensive, individualized, and compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.
In addition to his clinical practice, Dr. Qian serves as the Medical Director of Radiation Oncology at Stanford South Bay Cancer Center. He also serves as the Radiation Oncology Network Director of Clinical Research and has spearheaded opening of multiple NRG Oncology clinical trials at Stanford South Bay Cancer Center.
Dr. Qian is also actively involved in the Stanford Radiation Oncology residency program. He created and oversees a monthly mentorship roundtable series to assist residents with multiple aspects of their clinical training and career progression.
Outside of work, Dr. Qian enjoys spending time with his family and exploring the great outdoors of Northern California. -
Xiaojie Qiu
Assistant Professor of Genetics and, by courtesy, of Computer Science
Current Research and Scholarly InterestsAt the Qiu Lab, our mission is to unravel and predict the intricacies of gene regulatory networks and cell-cell interactions pivotal in mammalian cell fate transitions over time and space, with a special emphasis on heart evolution, development, and disease. We are a dynamic and interdisciplinary team, harnessing the latest advancements in machine learning as well as single-cell and spatial genomics by integrating the predictive power of systems biology with the scalability of machine learning,
-
Lisa Nguy Quach
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsTransitions of care, end-of-life care, care for vulnerable populations and patients with primary languages other than English, quality improvement, medical education, mentorship
-
Michael M. Quach, MD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Michael Quach, MD serves as Adjunct Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Quach is a board certified psychiatrist with over 20 years of administrative and clinical experience.
Dr. Quach completed his medical training at Stanford University School of Medicine and psychiatric residency training at Stanford Hospital and Clinics. He served as Chief Resident in the Stanford Department of Psychiatry and Behavioral Sciences and was recipient of the prestigious Stanford George Gulevich Humanistic Medicine Award in 2006.
Dr. Quach is board certified by the American Board of Psychiatry and Neurology (ABPN), and he is a Fellow of the American Psychiatric Association (FAPA). He is President of the Vietnamese Physician Assocation of Northern California. He is also President of the Viet-American Mental Health Network. He is an active member of the Northern California Psychiatric Society (NCPS), the California Psychiatric Association (CPA), the American Psychiatric Association (APA), and the Stanford Alumni Association (SAA).
Clinical Focus
•Psychiatry
•Psychopharmacology
•Psychotherapy
Academic Appointments
•Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Professional Education
•Medical Education: Stanford University School of Medicine
•Residency: Stanford Hospital and Clinics
•Board Certification: Psychiatry, American Board of Psychiatry and Neurology
•Fellow of the American Psychiatric Association (FAPA)
Community Work Experience
•Chief Operating Officer & Medical Director: Mekong Community Center (San Jose, CA)
•Chief Medical Officer: Momentum for Mental Health (San Jose, CA)
•Medical Director: Catholic Charities of Santa Clara County (San Jose, CA)
•Medical Director: Family and Children Services (San Jose, CA)
•Medical Director: Traditions Behavioral Health (San Jose, CA)
Publications
J Am Geriatr Soc. 1994 Nov;42(11):1218-9. Oral Temperature Changes and Cognitive Decline in Alzheimer Patients: A Possible Association. Robinson D, Omar SJ, Quach M, Yesavage JA, Tinklenberg J.
Current Work: Private Practice Psychiatrist in Willow Glen, San Jose, CA. -
Tom C Quach
Affiliate, Medicine - Med/Infectious Diseases
BioCoterminal Master's student at Stanford University, studying Community Health and Prevention Research.
I'm passionate about healthcare innovation, patient advocacy, and public health research. During my time at Stanford, I have collaborated closely with the Stanford Long COVID Clinic, working on clinical research surrounding the conditions pathophysiology and associations with ME/CFS, as well as national clinical trials for therapeutics. I have also conducted basic science research in the Helms Lab, examining healing trajectories for post-cleft surgical procedures. -
Stephen Quake
Lee Otterson Professor in the School of Engineering and Professor of Bioengineering, of Applied Physics and, by courtesy, of Physics
Current Research and Scholarly InterestsSingle molecule biophysics, precision force measurement, micro and nano fabrication with soft materials, integrated microfluidics and large scale biological automation.
-
Susan Y. Quan
Clinical Assistant Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
Staff, Medicine - Med/Gastroenterology and HepatologyBioClinical Focus:
Gastroenterology
Gastrointestinal Endoscopy
Board Certification:
Gastroenterology
Internal Medicine
Professional Education:
Fellowship: Stanford University School of Medicine, Gastroenterology and Hepatology (2014)
Residency: Johns Hopkins University School of Medicine, Internal Medicine (2011)
Medical Education: Johns Hopkins University School of Medicine (2008)
Undergraduate: Stanford University (2003) -
Thomas Quertermous, MD
William G. Irwin Professor of Cardiovascular Medicine
Current Research and Scholarly InterestsUnderstanding genetic basis of cardiovascular function and disease.
-
James Quinn
Professor of Emergency Medicine, Emeritus
Current Research and Scholarly InterestsDr. Quinn's primary focus is emergency care research with previous experience running large multi-center trials.. He has an extensive research background in clinical decision making involving patients with syncope, neurological emergencies and in the development and clinical evaluation of tissue adhesives. He is currently an emeritus professor whose academic activity is focused on the protection of human subjects in research. He remains clinically active in the Palo Alto Foundation Medical Group
